CN104434929B - 闭花木酮的o-(哌嗪基)乙基衍生物在制备抗急性肾衰药物中的应用 - Google Patents
闭花木酮的o-(哌嗪基)乙基衍生物在制备抗急性肾衰药物中的应用 Download PDFInfo
- Publication number
- CN104434929B CN104434929B CN201410618053.XA CN201410618053A CN104434929B CN 104434929 B CN104434929 B CN 104434929B CN 201410618053 A CN201410618053 A CN 201410618053A CN 104434929 B CN104434929 B CN 104434929B
- Authority
- CN
- China
- Prior art keywords
- cleistanone
- renal failure
- piperazinyl
- acute renal
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 C1[*+]CC*C1 Chemical compound C1[*+]CC*C1 0.000 description 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410618053.XA CN104434929B (zh) | 2014-11-05 | 2014-11-05 | 闭花木酮的o-(哌嗪基)乙基衍生物在制备抗急性肾衰药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410618053.XA CN104434929B (zh) | 2014-11-05 | 2014-11-05 | 闭花木酮的o-(哌嗪基)乙基衍生物在制备抗急性肾衰药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104434929A CN104434929A (zh) | 2015-03-25 |
CN104434929B true CN104434929B (zh) | 2016-10-05 |
Family
ID=52882194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410618053.XA Expired - Fee Related CN104434929B (zh) | 2014-11-05 | 2014-11-05 | 闭花木酮的o-(哌嗪基)乙基衍生物在制备抗急性肾衰药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104434929B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104784190A (zh) * | 2015-04-29 | 2015-07-22 | 南京大学 | 闭花木酮的o-(苯并咪唑基)乙基衍生物在制备抗急性肾衰药物中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198142A (zh) * | 2004-09-07 | 2011-09-28 | 太平洋艾瑞有限公司 | 带有当归酰基的抗肿瘤化合物 |
-
2014
- 2014-11-05 CN CN201410618053.XA patent/CN104434929B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104434929A (zh) | 2015-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104083385B (zh) | 闭花木酮Cleistanone的O-(哌啶基)乙基衍生物在制备升高白细胞的药物中的应用 | |
CN104083383B (zh) | 闭花木酮Cleistanone的O-(哌啶基)乙基衍生物在制备抗急性肾衰药物中的应用 | |
CN104095856B (zh) | 闭花木酮Cleistanone的二乙胺衍生物在制备抗急性肾衰药物中的应用 | |
CN104434929B (zh) | 闭花木酮的o-(哌嗪基)乙基衍生物在制备抗急性肾衰药物中的应用 | |
CN104188980B (zh) | 闭花木酮Cleistanone的O-(吗啉基)乙基衍生物、制备方法及其用途 | |
CN104083379B (zh) | 闭花木酮Cleistanone的二甲胺衍生物在制备抗鼻炎药物中的应用 | |
CN104784190A (zh) | 闭花木酮的o-(苯并咪唑基)乙基衍生物在制备抗急性肾衰药物中的应用 | |
CN104402964A (zh) | 闭花木酮的o-(咪唑基)乙基衍生物、制备方法及其用途 | |
CN105343082A (zh) | 组合物及其在抗急性肾衰药物中的应用 | |
CN105193793A (zh) | 组合物及其在抗急性肾衰药物中的应用 | |
CN104666310A (zh) | 闭花木酮的o-(三唑基)乙基衍生物在制备抗急性肾衰药物中的应用 | |
CN104758298A (zh) | 闭花木酮的o-(1h-四氮唑基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 | |
CN105267195A (zh) | 一种组合物及其在抗急性肾衰药物中的应用 | |
CN106822107A (zh) | Psiguadial A的咪唑基和二羟乙胺基衍生物组合物用于抗急性肾衰 | |
CN105287585A (zh) | 一种组合物及其在抗急性肾衰药物中的应用 | |
CN106074483A (zh) | Artalbic acid的衍生物的组合物用于制备抗急性肾衰药物 | |
CN106038542A (zh) | Artalbic acid衍生物的组合物用于制备抗急性肾衰药物 | |
CN105998002A (zh) | Salviskinone A的苯并咪唑基和二(2-甲硫基乙基)胺基衍生物的组合物在抗急性肾衰药物中的应用 | |
CN105343076A (zh) | 一种组合物及其在抗急性肾衰药物中的应用 | |
CN104906091A (zh) | Daphmalenine A的O-(二乙胺基)乙基衍生物在制备抗急性肾衰药物中的应用 | |
CN105853436A (zh) | Virosaine A的四氢吡咯基和吗啉基衍生物的组合物在抗急性肾衰药物中的应用 | |
CN105920005A (zh) | Virosaine A的哌嗪基和咪唑基衍生物的组合物在抗急性肾衰药物中的应用 | |
CN105287463A (zh) | 一种组合物及其在抗急性肾衰药物中的应用 | |
CN104784176A (zh) | Daphmalenine A衍生物在制备抗急性肾衰药物中的应用 | |
CN104814967A (zh) | 闭花木酮的o-(1h-四氮唑基)乙基衍生物在制备抗鼻炎药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Shiying Inventor before: Luo Dongjun Inventor before: Wu Junyi Inventor before: Huang Rong Inventor before: Wu Junhua |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160905 Address after: 475001 Huaihe Hospital of Henan University, 115 Simon Street, Kaifeng, Henan Applicant after: Wang Shiying Address before: Metro Technology Building No. 69 Olympic Avenue in Jianye District of Nanjing city in Jiangsu province 210019 01 5 storey buildings Applicant before: Nanjing Guangkangxie Biomedical Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20161005 Termination date: 20181105 |